Variations in corneal biomechanical parameters and central corneal thickness during the menstrual...
-
Upload
mary-hancock -
Category
Documents
-
view
212 -
download
0
Transcript of Variations in corneal biomechanical parameters and central corneal thickness during the menstrual...
Variations in corneal biomechanical Variations in corneal biomechanical
parameters and central corneal parameters and central corneal
thickness during the menstrual cycle.thickness during the menstrual cycle.
David Zadok, MD, Yakov Goldich, MD, David Zadok, MD, Yakov Goldich, MD, Yaniv Barkana, MD, Isaac Avni, MDYaniv Barkana, MD, Isaac Avni, MD
Department of OphthalmologyDepartment of Ophthalmology Assaf Harofeh Medical CenterAssaf Harofeh Medical Center
IsraelIsrael
The authors have no conflicts of interest and no financial interest in the article’s subject matter or methods mentioned.
BackgroundBackground
The cornea of women may be influenced by hormonal The cornea of women may be influenced by hormonal changes that occur during the monthly menstrual cycle.changes that occur during the monthly menstrual cycle.Cyclic variations in corneal topography and corneal Cyclic variations in corneal topography and corneal thickness have been previously described.thickness have been previously described.11
Corneal changes are probably driven by direct Corneal changes are probably driven by direct interaction of sex hormones with sex hormone receptors interaction of sex hormones with sex hormone receptors located in the human cornea.located in the human cornea.22
1. Kiely, P. M., L. G. Carney, et al. (1983). "Menstrual cycle variations of corneal topography and thickness." Am J Optom Physiol Opt 60(10): 822-9.
2. Gupta, P. D., K. Johar, Sr., et al. (2005). "Sex hormone receptors in the human eye." Surv Ophthalmol 50(3): 274-84.
BackgroundBackground The Ocular Response Analyzer (ORA; Reichert The Ocular Response Analyzer (ORA; Reichert
Inc, Buffalo, NY, USA) can be used to assess in-Inc, Buffalo, NY, USA) can be used to assess in-vivo corneal biomechanical properties, vivo corneal biomechanical properties, presented by two parameters, corneal hysteresis presented by two parameters, corneal hysteresis (CH) and corneal resistance factor (CRF).(CH) and corneal resistance factor (CRF).
These biomechanical parameters were proposed These biomechanical parameters were proposed to be used in addition to corneal thickness and to be used in addition to corneal thickness and topography for screening for corneal ectasia topography for screening for corneal ectasia before performing laser refractive procedures.before performing laser refractive procedures.33
3. Randleman, J. B. (2006). "Post-laser in-situ keratomileusis ectasia: current understanding and future directions." Curr Opin Ophthalmol 17(4): 406-12.
PurposePurpose
• The aim of our study was to The aim of our study was to evaluate whether there is a clinically evaluate whether there is a clinically meaningful variation in corneal meaningful variation in corneal biomechanical properties as biomechanical properties as measured by ORA during the measured by ORA during the menstrual cycle.menstrual cycle.
MethodsMethods
Twenty two young healthy women aged 19.5 ± 1.5 Twenty two young healthy women aged 19.5 ± 1.5 (mean ± SD) years were prospectively recruited from (mean ± SD) years were prospectively recruited from among the service staff of the Assaf Harofeh Medical among the service staff of the Assaf Harofeh Medical center.center.
Every participant was assessed at the beginning of the Every participant was assessed at the beginning of the menstrual cycle, then during ovulation, and at the end menstrual cycle, then during ovulation, and at the end of the cycle.of the cycle.
The following parameters were assessed:The following parameters were assessed: Corneal biomechanical parameters: corneal hysteresis and Corneal biomechanical parameters: corneal hysteresis and
corneal resistance factor.corneal resistance factor. Non-contact IOP with ORA: Goldmann correlated intraocular Non-contact IOP with ORA: Goldmann correlated intraocular
pressure (IOPg) and corneal compensated IOP (IOPcc). pressure (IOPg) and corneal compensated IOP (IOPcc). Central corneal thickness (CCT) with US pachymetryCentral corneal thickness (CCT) with US pachymetry
ResultsResultsTableTable . .Study parameters and their mean change and statistical significance during menstrual cycleStudy parameters and their mean change and statistical significance during menstrual cycle..
ParameterParameter
Onset of Onset of cyclecycle
OvulationOvulationEnd of End of cyclecycle
PP value value
Mean ± SDMean ± SDOnset vs Onset vs OvulatioOvulatio
nn
OvulatioOvulation vs Endn vs End
Onset vs EndOnset vs End
CCT (µm)CCT (µm) 535535 ± ± 4040 542542 ± ± 4141 543543 ± ± 4242 <<0.0010.001 0.5150.515 <<0.0010.001
CH (mmHg)CH (mmHg) 11.111.1 ± ± 1.41.4 10.110.1 ± ± 1.11.1 11.411.4 ± ± 1.81.8 <<0.0010.001 <<0.0010.001 0.0760.076
CRF (mmHg)CRF (mmHg) 10.610.6 ± ± 1.71.7 9.89.8 ± ± 1.61.6 10.510.5 ± ± 2.02.0 0.0010.001 0.0070.007 0.6730.673
IOPcc (mmHg)IOPcc (mmHg) 14.314.3 ± ± 2.72.7 15.315.3 ± ± 3.93.9 13.613.6 ± ± 2.82.8 0.1920.192 0.0650.065 0.0630.063
IOPg (mmHg)IOPg (mmHg) 14.614.6 ± ± 3.23.2 14.914.9 ± ± 4.24.2 13.913.9 ± ± 3.13.1 0.5400.540 0.0970.097 0.1400.140
CCT=central corneal thickness, CH=corneal hysteresis, CRF=corneal resistance factor, IOPcc=corneal-compensated CCT=central corneal thickness, CH=corneal hysteresis, CRF=corneal resistance factor, IOPcc=corneal-compensated intraocular pressure; IOPg=Goldmann-correlated intraocular pressureintraocular pressure; IOPg=Goldmann-correlated intraocular pressure
ResultsResults
FIGURE 1. Box and whisker plots (smallest, median and largest values with FIGURE 1. Box and whisker plots (smallest, median and largest values with interquartile range) showing corneal hysteresis at three different time points interquartile range) showing corneal hysteresis at three different time points during menstrual cycle.during menstrual cycle.
5.00
7.00
9.00
11.00
13.00
15.00
17.00
Onset Ovulation End
Co
rne
al H
ys
tere
sis
(m
mH
g)
ResultsResults
FIGURE 2. Box and whisker plots (smallest, median and largest values with FIGURE 2. Box and whisker plots (smallest, median and largest values with interquartile range) showing corneal resistance factor at three different time interquartile range) showing corneal resistance factor at three different time points during menstrual cycle.points during menstrual cycle.
5.00
6.00
7.00
8.00
9.00
10.00
11.00
12.00
13.00
14.00
15.00
16.00
17.00
Onset Ovulation End
Co
rne
al
Re
sis
tan
ce
Fa
cto
r (m
mH
g)
ResultsResults
FIGURE 3. Box and whisker plots (smallest, median and largest values with FIGURE 3. Box and whisker plots (smallest, median and largest values with interquartile range) showing central corneal thickness at three different time interquartile range) showing central corneal thickness at three different time points during menstrual cycle.points during menstrual cycle.
400
450
500
550
600
650
Onset Ovulation End
Ce
ntr
al C
orn
ea
l T
hic
kn
es
s (
µm
)
ConclusionsConclusions Corneal thickness and biomechanical parameters significantly vary Corneal thickness and biomechanical parameters significantly vary
during menstrual cycle.during menstrual cycle.
The central cornea is thinnest at the beginning and significantly thicker at The central cornea is thinnest at the beginning and significantly thicker at
ovulation and at the end of the cycle.ovulation and at the end of the cycle.
CH and CRF are statistically significantly decreased at ovulation as CH and CRF are statistically significantly decreased at ovulation as
difference between values at the beginning and the end compared with the difference between values at the beginning and the end compared with the
other two time points, with no statistically significant of the cycle. other two time points, with no statistically significant of the cycle.
Cyclical corneal alterations may need to be considered when planning Cyclical corneal alterations may need to be considered when planning
corneal refractive surgery. corneal refractive surgery.
Correspondence: David Zadok MD, E-mail: [email protected]